|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02415 MEDSCI
Nominal 
0.990 -0.010 (-1.000%) | 2025/12 - Final RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 2,022 | 54,814 | 38,036 | (14,042) | 37,351 |
| Net Cash from / (used in) Investing Activities | 13,049 | (316,700) | (494,974) | (2,133) | (2,034) |
| Net Cash from / (used in) Financing Activities | (10,350) | (4,423) | 470,928 | (7,516) | 285,556 |
| Increase / (Decrease) in Cash & Cash Equivalents | 4,721 | (266,309) | 13,990 | (23,691) | 320,873 |
| Cash & Cash Equivalents at beginning of period | 366,940 | 628,588 | 599,266 | 596,002 | 276,972 |
| Effect of Foreign Exchange Rate Changes | (3,927) | 4,661 | 15,332 | 26,955 | (1,843) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 367,734 | 366,940 | 628,588 | 599,266 | 596,002 |
| Remarks: | Real time quote last updated: 04/06/2026 14:51 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 17,937 |
| %Change | -28.157% |
| EPS / (LPS) | RMB 0.030 |
| NBV Per Share (¥) | RMB 1.945 |